Get started
Author

Steven Kowalyk

MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
2018 · Hannah Major-Monfried, Anne S. Renteria, et al. · Blood · 213
PDF
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
2019 · Hrishikesh K. Srinagesh, Umut Özbek, et al. · Blood Advances · 111
PDF
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD
2023 · Yu Akahoshi, Nikolaos Spyrou, et al. · Blood Advances · 46
PDF
Effective treatment of low-risk acute GVHD with itacitinib monotherapy
2022 · Aaron Etra, Alexandra Capellini, et al. · Blood · 42
PDF
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
2020 · Stephanie C. Gergoudis, Zachariah DeFilipp, et al. · Blood Advances · 38
PDF
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD
2024 · Yu Akahoshi, Nikolaos Spyrou, et al. · Blood · 37
PDF
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification
2022 · Aaron Etra, Stephanie Gergoudis, et al. · Blood Advances · 37
PDF
Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant
2020 · Mina D. Aziz, Jay Shah, et al. · Leukemia · 34
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
2023 · Monzr M. Al Malki, Kaitlyn London, et al. · Blood Advances · 25
PDF
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
2024 · Zachariah DeFilipp, Haesook T. Kim, et al. · Blood Advances · 23
PDF
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease
2021 · Makda Getachew Zewde, George Morales, et al. · Transplantation and Cellular Therapy · 20
Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD
2024 · Aaron Etra, Najla El Jurdi, et al. · Blood Advances · 19
PDF
The utility of biomarkers in acute GVHD prognostication
2023 · Nikolaos Spyrou, Yu Akahoshi, et al. · Blood Advances · 19
PDF
Assessment and Molecular Characterization of Human Intestinal Parasites in Bivalves from Orchard Beach, NY, USA
2016 · Freda Tei, Steven Kowalyk, et al. · International Journal of Environmental Research and Public Health · 19
PDF
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis
2024 · Yu Akahoshi, Nikolaos Spyrou, et al. · Blood Advances · 18
PDF
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD
2024 · Muna Qayed, Urvi Kapoor, et al. · Transplantation and Cellular Therapy · 14
Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers
2021 · Stelios Kasikis, Janna Baez, et al. · Bone Marrow Transplantation · 12
A Day 14 Endpoint for Acute GVHD Clinical Trials
2024 · Nikolaos Spyrou, Yu Akahoshi, et al. · Transplantation and Cellular Therapy · 10
The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD
2025 · Yu Akahoshi, Joseph Portelli, et al. · Blood Advances · 8
PDF
Comparison of Gvhd Biomarker Algorithms for Predicting Lethal Gvhd and Non-Relapse Mortality
2019 · Aaron Etra, Stephanie Gergoudis, et al. · Transplantation and Cellular Therapy · 5
Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients
2024 · Carlos A. Ortega Rios, Muna Qayed, et al. · Transplantation and Cellular Therapy · 2
The Mount Sinai Acute Gvhd International Consortium (MAGIC) Model: An Integrated Clinical and Biomarker Grading System for Acute Graft-Versus-Host Disease (GVHD)
2024 · Yu Akahoshi, Nikolaos Spyrou, et al. · Transplantation and Cellular Therapy · 2
The MAGIC Algorithm Probability (MAP) Is a Validated Response Biomarker of Treatment for Acute Graft-Versus-Host Disease
2020 · Hrishikesh K. Srinagesh, Umut Ozbek, et al. · Transplantation and Cellular Therapy · 2
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group
2024 · Nikolaos Katsivelos, Nikolaos Spyrou, et al. · Transplantation and Cellular Therapy · 1
The MAGIC Algorithm Probability Predicts Treatment Response and Long-Term Outcomes to Second-Line Therapy for Acute Gvhd
2024 · Zachariah DeFilipp, Haesook T Kim, et al. · Transplantation and Cellular Therapy · 1
Works count: 34
Citation count: 757
H-index: 15
I10-index: 18
Year
Topic
Type